• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies.评估人癌胚抗原(CEA)转导和未转导的鼠肿瘤作为抗CEA疗法潜在靶点的情况。
Cancer Immunol Immunother. 1993;36(2):65-75. doi: 10.1007/BF01754404.
2
Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line.
Cancer Res. 1991 Jul 15;51(14):3657-62.
3
Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.转人癌胚抗原基因小鼠作为免疫治疗模型
Cancer Res. 1998 Apr 1;58(7):1469-77.
4
Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.在人癌胚抗原转基因小鼠模型中用放射性标记抗体进行肿瘤靶向研究。
Int J Cancer. 2000 Mar 15;85(6):751-6. doi: 10.1002/(sici)1097-0215(20000315)85:6<751::aid-ijc2>3.0.co;2-8.
5
Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen.一种模拟癌胚抗原的抗独特型抗体诱导抗肿瘤免疫
Cancer Res. 1997 Feb 15;57(4):728-34.
6
Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.用重组腺病毒转导的树突状细胞比用肽脉冲处理的树突状细胞诱导更有效的抗肿瘤免疫。
Vaccine. 2006 Apr 5;24(15):2860-8. doi: 10.1016/j.vaccine.2005.12.056. Epub 2006 Jan 13.
7
Tumor localization of CEA-containing human tumors in nude mice by means of monoclonal anti-CEA antibodies.利用单克隆抗癌胚抗原抗体对裸鼠体内含癌胚抗原的人类肿瘤进行肿瘤定位。
Int J Cancer. 1982 Nov 15;30(5):547-52. doi: 10.1002/ijc.2910300503.
8
Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats.在大鼠癌细胞中表达的人癌胚抗原cDNA,可作为裸鼠体内抗体肿瘤定位的靶抗原,以及同基因大鼠体内的排斥抗原发挥作用。
Int J Cancer. 1992 Aug 19;52(1):110-9. doi: 10.1002/ijc.2910520120.
9
Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.用治疗剂量的90Y-α-癌胚抗原单克隆抗体治疗后复发的人结肠癌的癌胚抗原表达
Cancer Res. 1991 Jul 15;51(14):3802-6.
10
In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.与抗原性MHC I类复合物偶联的抗肿瘤抗体在体内的靶向作用可诱导已建立的同基因肿瘤移植瘤发生特异性生长抑制和消退。
Cancer Immun. 2003 Aug 14;3:11.

引用本文的文献

1
Cancer co-opts differentiation of B-cell precursors into macrophage-like cells.癌症将 B 细胞前体诱导向巨噬细胞样细胞分化。
Nat Commun. 2022 Sep 14;13(1):5376. doi: 10.1038/s41467-022-33117-y.
2
FOLFOX Chemotherapy Ameliorates CD8 T Lymphocyte Exhaustion and Enhances Checkpoint Blockade Efficacy in Colorectal Cancer.FOLFOX化疗改善CD8 T淋巴细胞耗竭并增强结直肠癌中检查点阻断疗法的疗效。
Front Oncol. 2020 Apr 23;10:586. doi: 10.3389/fonc.2020.00586. eCollection 2020.
3
Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice.使用64Cu标记的癌胚抗原(CEA)抗体在转基因小鼠中通过正电子发射断层扫描(PET)对肝转移灶进行放射免疫显像。
PLoS One. 2014 Sep 16;9(9):e106921. doi: 10.1371/journal.pone.0106921. eCollection 2014.
4
Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy.舒尼替尼给药方案对宿主免疫反应元件和疫苗联合治疗的影响。
Int J Cancer. 2012 Apr 15;130(8):1948-59. doi: 10.1002/ijc.26219. Epub 2011 Aug 8.
5
Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells.采用嵌合抗原受体转导的同种 T 细胞过继转移可消除淋巴瘤和正常 B 细胞。
Blood. 2010 Nov 11;116(19):3875-86. doi: 10.1182/blood-2010-01-265041. Epub 2010 Jul 14.
6
Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.在自发性结直肠癌转基因小鼠模型中的抗体靶向研究。
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10256-60. doi: 10.1073/pnas.181353498. Epub 2001 Aug 21.
7
Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer.用于乳腺癌免疫治疗的重组疫苗开发策略。
Breast Cancer Res Treat. 1996;38(1):27-39. doi: 10.1007/BF01803781.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Reactivity of a monoclonal antibody with human ovarian carcinoma.一种单克隆抗体与人卵巢癌的反应性。
J Clin Invest. 1981 Nov;68(5):1331-7. doi: 10.1172/jci110380.
3
Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody.通过单克隆抗体对无胸腺小鼠体内人乳腺肿瘤进行放射性定位。
Cancer Res. 1983 Feb;43(2):736-42.
4
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.逆转录病毒包装突变体的构建及其用于产生无辅助病毒的缺陷型逆转录病毒。
Cell. 1983 May;33(1):153-9. doi: 10.1016/0092-8674(83)90344-6.
5
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.一种新型单克隆抗体(DF3)对人类恶性与良性乳腺肿瘤的不同反应性。
Hybridoma. 1984 Fall;3(3):223-32. doi: 10.1089/hyb.1984.3.223.
6
Specific carcinoembryonic antigens of the human digestive system.人类消化系统的特异性癌胚抗原。
J Exp Med. 1965 Sep 1;122(3):467-81. doi: 10.1084/jem.122.3.467.
7
Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.用单克隆抗体B72.3鉴定的一种人类肿瘤相关糖蛋白(TAG-72)的分析
Cancer Res. 1986 Feb;46(2):850-7.
8
Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence.从cDNA序列推导的人癌胚抗原(CEA)的一级结构。
Biochem Biophys Res Commun. 1987 Jan 30;142(2):511-8. doi: 10.1016/0006-291x(87)90304-4.
9
Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen.人癌胚抗原全长功能性cDNA克隆的分离与鉴定
Mol Cell Biol. 1987 Sep;7(9):3221-30. doi: 10.1128/mcb.7.9.3221-3230.1987.
10
Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.单克隆抗体在癌症治疗中的基本原理与应用:理查德与欣达·罗森塔尔基金会奖讲座
Cancer Res. 1986 Jul;46(7):3225-38.

评估人癌胚抗原(CEA)转导和未转导的鼠肿瘤作为抗CEA疗法潜在靶点的情况。

Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies.

作者信息

Hand P H, Robbins P F, Salgaller M L, Poole D J, Schlom J

机构信息

Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

出版信息

Cancer Immunol Immunother. 1993;36(2):65-75. doi: 10.1007/BF01754404.

DOI:10.1007/BF01754404
PMID:8425211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11037972/
Abstract

The MC-38 C57BL/6 mouse colon adenocarcinoma cell line has been transduced with a retroviral construct containing cDNA encoding the human carcinoembryonic antigen (CEA) gene [Robbins PF, Kantor JA, Salgaller M, Horan Hand P, Fernsten PD, Schlom J (1991) Cancer Res 51: 3657]. Two clones, MC-38-ceal and MC-38-cea2, expressed high levels of CEA on their cell surface. A third CEA-expressing cell line, MCA-102-cea3, was similarly derived by transduction of the MCA-102 C57BL/6 mouse fibrosarcoma cell line and is described here. In this study, the three CEA-transduced murine tumor cell lines (MC-38-ceal, MC-38-cea2, MCA-102-cea3) were evaluated for their tumorigenic potential, as well as their ability to serve as in vivo model systems for active and passive immunotherapy studies. Parameters that were investigated include tumor growth rate, the antibody response of the host to CEA, and the CEA content of the tumors. The MC-38-cea2 model appeared to be the most appropriate for immunotherapy studies. Biodistribution studies, using an 125I-labeled anti-CEA mAb, demonstrated efficient tumor targeting of MC-38-cea2 tumors in C57BL/6 and athymic mice.

摘要

MC-38 C57BL/6小鼠结肠腺癌细胞系已用一种逆转录病毒构建体进行转导,该构建体包含编码人癌胚抗原(CEA)基因的cDNA[罗宾斯PF,坎托JA,萨尔加勒M,霍兰·汉德P,费恩斯滕PD,施洛姆J(1991年)《癌症研究》51: 3657]。两个克隆,MC-38-ceal和MC-38-cea2,在其细胞表面高水平表达CEA。第三个表达CEA的细胞系,MCA-102-cea3,是通过转导MCA-102 C57BL/6小鼠纤维肉瘤细胞系类似获得的,在此进行描述。在本研究中,评估了三种转导CEA的小鼠肿瘤细胞系(MC-38-ceal、MC-38-cea2、MCA-102-cea3)的致瘤潜力,以及它们作为主动和被动免疫治疗研究体内模型系统的能力。研究的参数包括肿瘤生长速率、宿主对CEA的抗体反应以及肿瘤的CEA含量。MC-38-cea2模型似乎最适合免疫治疗研究。使用125I标记的抗CEA单克隆抗体进行的生物分布研究表明,MC-38-cea2肿瘤在C57BL/6和无胸腺小鼠中能有效靶向肿瘤。